{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Management of the Febrile Young Infant

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Summarize the changing epidemiology of serious bacterial infections and invasive bacterial infections in febrile infants aged 90 days or younger in the vaccine era.
  2. Discuss the strengths and weaknesses of previously established clinical prediction models for febrile infants in the vaccine era.
  3. Describe the current literature on novel biomarkers including C-reactive protein, procalcitonin, and RNA biosignatures for identification of bacterial infection in febrile infants.
Price: FREE

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PEC1117
Published: November 2017
Expires: 1/1/2026
Required Passing Score: 4/5 (80%)
Authors: Christopher Woll, MD, Mark I. Neuman, MD, MPH, and Paul L. Aronson, MD
Categories: Pediatrics
Specialties: Pediatrics